TERMIUM Plus^®

Record 1,  Textual support,  English

Record number: 1, Textual support number: 1 OBS

Reviews the prices of patented medicines sold in Canada to ensure that they are not excessive; encourages patentees to comply voluntarily with the Board‘s Excessive Price Guidelines; implements related compliance and enforcement policies; and investigates complaints into the prices of patented medicines. The Regulatory Affairs and Outreach Branch also promotes interaction with patentees.  1, record 1, English, - Regulatory%20Affairs%20and%20Outreach%20Branch

Record 1,  Textual support,  French

Record number: 1, Textual support number: 1 OBS

La direction Affaires réglementaires et liaison auprès des brevetés fait l'examen des prix des médicaments brevetés vendus au Canada pour s’assurer qu'ils ne sont pas excessifs, encourage les brevetés à se conformer volontairement aux Lignes directrices du Conseil sur les prix excessifs, veille à la bonne application des politiques de conformité et d’application et fait enquête sur les plaintes reçues concernant les prix de certains médicaments brevetés. La Direction facilite également les interactions du CEPMB avec les brevetés.  1, record 1, French, - direction%20Affaires%20r%C3%A9glementaires%20et%20liaison%20aupr%C3%A8s%20des%20brevet%C3%A9s

Record 1,  Textual support,  Spanish

Record 2,  Textual support,  English

Record number: 2, Textual support number: 1 OBS

Discussion Paper of the Patented Medicine Prices Review Board, January 31, 2008.  1, record 2, English, - Options%20for%20Possible%20Changes%20to%20the%20Patented%20Medicines%20Regulations%2C%201994%20and%20the%20Excessive%20Price%20Guidelines

Record 2,  Textual support,  French

Record number: 2, Textual support number: 1 OBS

Document de discussion du Conseil d’examen du prix des médicaments brevetés, le 31 janvier 2008.  1, record 2, French, - Changements%20qui%20pourraient%20%C3%AAtre%20apport%C3%A9s%20au%20R%C3%A8glement%20sur%20les%20m%C3%A9dicaments%20brevet%C3%A9s%2C%201994%20et%20aux%20Lignes%20directrices%20sur%20les%20prix%20excessifs

Record 2,  Textual support,  Spanish

Record 3,  Textual support,  English

Record number: 3, Textual support number: 1 OBS

Patented Medicine Prices Review Board, May 2006. The purpose is to obtain written feedback on specific elements of the Guidelines used to determine whether the prices of patented medicines are excessive, including ideas on possible options for change.  1, record 3, English, - Discussion%20Guide%20for%20the%20Consultations%20on%20the%20Board%27s%20Excessive%20Price%20Guidelines

Record 3,  Textual support,  French

Record number: 3, Textual support number: 1 OBS

Conseil d’examen du prix des médicaments brevetés, mai 2006. L’objectif du Guide de discussion est d’obtenir les commentaires écrits des intervenants concernant certains facteurs dont le personnel du Conseil doit tenir compte dans son examen du prix d’un médicament breveté ainsi que des suggestions de changements.  1, record 3, French, - Guide%20de%20discussion%20aux%20fins%20de%20consultation%20sur%20les%20Lignes%20directrices%20du%20Conseil%20sur%20les%20prix%20excessifs

Record 3,  Textual support,  Spanish

Record 4,  Textual support,  English

Record number: 4, Textual support number: 1 OBS

The Patented Medicine Prices Review Board's Guidelines on Excessive Prices are based on the factors in the Act and, among other things, they provide that increases in the price of an existing patented drug should not be greater than increases in the CPI (Consumer Price Index).  1, record 4, English, - Guidelines%20on%20Excessive%20Prices

Record 4,  Textual support,  French

Record number: 4, Textual support number: 1 OBS

Du Conseil d’examen des prix des médicaments brevetés. Les lignes directrices limitent la majoration des prix des médicaments existants aux variations de l’Indice des prix à la consommation (IPC).  1, record 4, French, - Lignes%20directrices%20sur%20les%20prix%20excessifs

Record 4,  Textual support,  Spanish